IP Library Granted Patent US 11,060,072
Granted Patent B2
US 11,060,072 · App. 16/525,834 · Granted Jul 13, 2021

Engineered imine reductases and methods for the reductive amination of ketone and amine compounds

Inventors: Nicholas J. Agard (San Francisco, CA); Oscar Alvizo (Fremont, CA); Melissa Ann Mayo (Foster City, CA); Stefanie Ng Minor (Redwood City, CA); James Nicholas Riggins (San Francisco, CA); Jeffrey C. Moore (Westfield, NJ)
Assignee: Codexis, Inc.
C12N9/0028C12P13/001C12P17/10C12Y105/01028
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,060,072
App. No.
16/525,834
Granted
Jul 13, 2021
Kind
B2
Abstract

The present application provides engineered polypeptides having imine reductase activity, polynucleotides encoding the engineered imine reductases, host cells capable of expressing the engineered imine reductases, and methods of using these engineered polypeptides with a range of ketone and amine substrate compounds to prepare secondary and tertiary amine product compounds.

Claims (28)

1. A process for preparing an amine compound of formula (III),

wherein

R 1 and R 2 groups are independently selected from a hydrogen atom, and optionally substituted alkyl, alkenyl, alkynyl, alkoxy, carboxy, aminocarbonyl, heteroalkyl, heteroalkenyl, heteroalkynyl, carboxyalkyl, aminoalkyl, haloalkyl, alkylthioalkyl, cycloalkyl, aryl, arylalkyl, heterocycloalkyl, heteroaryl, and heteroarylalkyl; and optionally R 1 and R 2 are linked to form a 3-membered to 10-membered ring;

R 3 and R 4 groups are independently selected from a hydrogen atom, and optionally substituted alkyl, alkenyl, alkynyl, alkoxy, carboxy, aminocarbonyl, heteroalkyl, heteroalkenyl, heteroalkynyl, carboxyalkyl, aminoalkyl, haloalkyl, alkylthioalkyl, cycloalkyl, aryl, arylalkyl, heterocycloalkyl, heteroaryl, and heteroarylalkyl, with the proviso that both R 3 and R 4 cannot be hydrogen; and optionally R 3 and R 4 are linked to form a 3-membered to 10-membered ring; and

optionally, the carbon atom and/or the nitrogen indicated by * is chiral;

the process comprising contacting

a compound of formula (I),

wherein

R 1 , and R 2 are as defined above;

and

a compound of formula (II),

wherein

R 3 , and R 4 are as defined above;

with an engineered polypeptide, wherein the engineered polypeptide has imine reductase activity in presence of a cofactor under suitable reaction conditions and wherein the engineered polypeptide comprises an amino acid sequence with at least 90 sequence identity to a reference sequence of SEQ ID NO:6 and a residue difference at position 82, as compared to SEQ ID NO:6.

2. The process of claim 1 , in which R 3 and R 4 are linked to form a 3-membered to 10-membered ring.

3. The process of claim 1 , in which the substrate compound of formula (II) is butylamine.

4. The process of claim 1 , in which at least one of R 1 and R 2 of the compound of formula (I) is linked to at least one of R 3 and R 4 of the amine compound of formula (II), whereby the process for preparing the amine compound of formula (III) comprises an intramolecular reaction.

5. The process of claim 1 , in which the suitable reaction conditions comprise:

(a) substrate loading at about 10 g/L to 100 g/L;

(b) about 0.1 g/L to about 50 g/L of the engineered polypeptide;

(c) about 0.05 g/L (0.001 M) to about 2.5 g/L (0.050 M) of NAD(P)H;

(d) a pH of about 6 to 10;

(e) temperature of about 20° to 50° C.; and

(f) reaction time of 2-120 hrs.

6. The process of claim 1 , in which the substrate compound of formula (I) is compound (1j):

7. The process of claim 1 , wherein the process comprises contacting butylamine and the substrate compound (1j):

with an engineered polypeptide, wherein the engineered polypeptide has imine reductase activity in the presence of a cofactor under suitable reaction conditions and wherein the engineered polypeptide comprises an amino acid sequence with at least 90 sequence identity to a reference sequence of SEQ ID NO:6 and a residue difference at position 82, as compared to SEQ ID NO:6,

to produce the product of compound (3o):

Assignments (1)
SECURITY INTEREST Recorded Feb 15, 2024
From: CODEXIS, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT
Reel/Frame 066600/0650 →
Continuity (6)
Division 15783657 · Oct 13, 2017
Division 14539690 · Nov 12, 2014
Provisional Application 61903772 · Nov 13, 2013
Provisional Application 62022315 · Jul 9, 2014
Provisional Application 62022323 · Jul 9, 2014
Related Publication 20190345458A1 · Nov 14, 2019